Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.34M Sell
9,484
-899
-9% -$320K 1.71% 11
2025
Q4
$3.4M Sell
10,383
-150
-1% -$47.6K 1.74% 12
2025
Q3
$2.97M Buy
10,533
+201
+2% +$58.3K 1.58% 15
2025
Q2
$2.88M Buy
10,332
+2
+0% +$567 1.63% 14
2025
Q1
$3.22M Sell
10,330
-74
-0.7% -$21.9K 1.93% 10
2024
Q4
$2.71M Buy
10,404
+221
+2% +$65.6K 1.59% 16
2024
Q3
$3.28M Buy
+10,183
New +$3.33M 2.02% 9

Other funds holding AMGN

Tudor Financial's AMGN Position: Q1 2026 in Review

Tudor Financial reduced its Amgen (AMGN) stake by 8.7% in Q1 2026, selling an estimated $320K and leaving 9,484 shares worth $3.34M. The position accounts for 1.71% of the portfolio, ranked #11.

Tudor Financial first reported a position in AMGN in Q3 2024 and has held it in 7 quarters since. The position peaked at $3.4M in Q4 2025. 3,130 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Tudor Financial held 9,484 shares of Amgen worth $3.34M as of Q1 2026.
  • Tudor Financial sold 899 Amgen shares in Q1 2026, an estimated $320K.
  • Amgen made up 1.71% of Tudor Financial's portfolio in Q1 2026, its #11 holding.
  • Tudor Financial first reported a position in Amgen in Q3 2024 and has held it in 7 quarters since.
  • Tudor Financial's Amgen position peaked at $3.4M in Q4 2025.
  • 3,130 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Tudor Financial's 13F filing for Q1 2026, filed 14 May 2026.